133 related articles for article (PubMed ID: 37980969)
41. A Rare Case of Factor VII Inhibitor in a Patient Presenting with Primary Splenic Marginal Zone Lymphoma.
Naismith K; Allevato PA; Hamm C
Am J Case Rep; 2021 Sep; 22():e932704. PubMed ID: 34487513
[TBL] [Abstract][Full Text] [Related]
42. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G; Rojas-Rivera J; Logt AV; Justino J; Sevillano A; Caravaca-Fontán F; Ávila A; Rabasco C; Cabello V; Varela A; Díez M; Martín-Reyes G; Diezhandino MG; Quintana LF; Agraz I; Gómez-Martino JR; Cao M; Rodríguez-Moreno A; Rivas B; Galeano C; Bonet J; Romera A; Shabaka A; Plaisier E; Espinosa M; Egido J; Segarra A; Lambeau G; Ronco P; Wetzels J; Praga M;
Kidney Int; 2021 Apr; 99(4):986-998. PubMed ID: 33166580
[TBL] [Abstract][Full Text] [Related]
43. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
44. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
45. Partial splenectomy for children with congenital hemolytic anemia and massive splenomegaly.
Diesen DL; Zimmerman SA; Thornburg CD; Ware RE; Skinner M; Oldham KT; Rice HE
J Pediatr Surg; 2008 Mar; 43(3):466-72. PubMed ID: 18358283
[TBL] [Abstract][Full Text] [Related]
46. Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.
Ghanima W; Khelif A; Waage A; Michel M; Tjønnfjord GE; Romdhan NB; Kahrs J; Darne B; Holme PA;
Lancet; 2015 Apr; 385(9978):1653-61. PubMed ID: 25662413
[TBL] [Abstract][Full Text] [Related]
47. [Guidelines for therapy of idiopathic thrombocytopenic purpura (ITP) in childhood].
Gadner H; Grümayer ER; Haas OA
Klin Padiatr; 1986; 198(4):299-305. PubMed ID: 3762002
[TBL] [Abstract][Full Text] [Related]
48. The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.
Palandri F; Polverelli N; Catani L; Sollazzo D; Romano M; Levorato M; Vianelli N
Am J Hematol; 2014 Nov; 89(11):1047-50. PubMed ID: 25103500
[TBL] [Abstract][Full Text] [Related]
49. Current treatment strategies in autoimmune hemolytic disorders.
Barcellini W
Expert Rev Hematol; 2015 Oct; 8(5):681-91. PubMed ID: 26343892
[TBL] [Abstract][Full Text] [Related]
50. Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Vassilakopoulos TP
Best Pract Res Clin Haematol; 2018 Mar; 31(1):65-72. PubMed ID: 29452668
[TBL] [Abstract][Full Text] [Related]
51. Pediatric Autoimmune Bullous Disease: A Literature Review and Update on Management.
Ashton R; Fassihi H
Pediatr Rev; 2022 Jun; 43(6):309-321. PubMed ID: 35641451
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory pseudotumor of spleen. Report of two cases and literature review.
Galindo Gallego M; Ortega Serrano MP; Ortega Lopez M; Esteban Collazo F; Guinea Esquerdo L
Minerva Chir; 1997 Nov; 52(11):1379-88. PubMed ID: 9489339
[TBL] [Abstract][Full Text] [Related]
53. Treatment of idiopathic thrombocytopenic purpura in adults. Long-term results in a series of 41 patients.
Ikkala E; Kivilaakso E; Kotilainen M; Hästbacka J
Ann Clin Res; 1978 Apr; 10(2):83-6. PubMed ID: 567032
[TBL] [Abstract][Full Text] [Related]
54. [Clinical significant of splenectomy for fever of unknown origin with splenomegaly].
Yang ZY; Han B; Yang T; Gao WS; Sang XT; Duan MH; Zhao YQ; Shen T
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3385-8. PubMed ID: 17313846
[TBL] [Abstract][Full Text] [Related]
55. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
56. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
Reguiaï Z; Tchen T; Perceau G; Bernard P
Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
[TBL] [Abstract][Full Text] [Related]
57. Pharmacotherapeutic management of pulmonary sarcoidosis.
Fazzi P
Am J Respir Med; 2003; 2(4):311-20. PubMed ID: 14719997
[TBL] [Abstract][Full Text] [Related]
58. Grand rounds. Immune globulin in the treatment of autoimmune thrombocytopenic purpura.
Wordell CJ; Stubits EA; Tietze KJ; Gaska JA; Cosgrove EM
Clin Pharm; 1985; 4(2):206-13. PubMed ID: 4039241
[TBL] [Abstract][Full Text] [Related]
59. Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.
Olszewski AJ; Ali S
Ann Hematol; 2014 Mar; 93(3):449-58. PubMed ID: 24057925
[TBL] [Abstract][Full Text] [Related]
60. Two cases of splenic neoplasms with differing imaging findings that required laparoscopic resection for a definitive diagnosis.
Hiyama K; Kirino I; Fukui Y; Terashima H
Int J Surg Case Rep; 2022 Apr; 93():107023. PubMed ID: 35477212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
